| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
| mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
3e-05 |
| mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
4e-05 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
6e-05 |
| mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
6e-05 |
| mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
7e-05 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |